Tirzepatide is a dual GIP and GLP-1 receptor agonist approved by the FDA for type 2 diabetes management (Mounjaro) and chronic weight management (Zepbound) in adults with obesity or overweight with weight-related comorbidities
(1) Synthesis of Boc protected amino acids: Dissolve the required amino acids in dichloromethane, add potassium carbonate powder, stir evenly, add ethoxylated silica gel, continue stirring, and then add pyridine and N-methylmorpholine to obtain Boc protected amino acids
Both Ozempic and the generic semaglutide products are approved by Health Canada for management of diabetes, but for years doctors prescribed it off-label for weight loss before manufacturer Novo Nordisk began selling Wegovy in Canada in 2024
As a potent mitochondrial redox regulator, CoQ10 could prevent thrombotic events in COVID-19 and PASC patients by resolving ROS-induced platelet aggregation 539
Global incumbents (Novo, Lilly) have mixed results, creating an opportunity for Chinese players
